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Translational neuroscience is voguish; this scientific discipline 
tries to translate understanding of the basic biological back-
ground of central nervous system disorders to theories of how 
these disorders can be prevented or treated. At the same time, 
functional neuroimaging techniques have become the most 
important tools in determining the effects of diseases and their 
treatment on the brain systems related to mental functions and 
behaviour. An important limitation of common functional mag-
netic resonance imaging (fMRI) is its relatively low spatial and 
temporal resolution which hampers the study of small and com-
plex structures, for example, the habenuloid complex, when these 
are not specifically addressed (Batalla et al., 2017). Approximately 
three-quarters of the human brain consists of cerebral neocortex 
(Voogd et al., 1998), and since the cerebral cortex shows intricate 
functional connectivity which is easily accessible for fMRI 
research, huge efforts have been made to establish its role in the 
pathogenesis and treatment mechanisms of mental disorders (e.g. 
Rolls, 2016; Rolls et al., 2018). The human cerebral cortex and 
corresponding parts of the dorsal thalamus appeared very late 
during vertebrate evolution: in early mammals evolving about 
145 million years ago (MYA) (Voogd et al., 1998). The habenu-
loid complex was already an important component of the brains 
of ancestors preceding the earliest vertebrates of about 560 MYA, 
and this structure maintained its output connectivity with the 
ascending monoaminergic systems of the midbrain during the 
entirety of evolution from these earliest vertebrates right up to 
modern humans (see Loonen and Ivanova, 2015, 2016b). These 
early vertebrates had brains comparable to those of the modern 
lamprey, and since they must have been capable of obtaining 
food, offspring and safety, their brains must also have been capa-
ble of regulating the corresponding reward-seeking and distress-
avoiding behaviours. Dysregulation of these two types of 
behaviour can be considered to represent the fundamental origin 
of the majority of mood, anxiety, addictive and psychotic disor-
ders. The lamprey brain can, therefore, be applied to the study of 
the basic biological processes causing such disorders, and, more-
over, those parts of the human brain corresponding to the ancient 
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vertebrate brain may well be considered to be primarily involved 
in causing these disorders.
Evolution of the forebrain in 
vertebrates
The lamprey forebrain consists of a two-sided hemisphere with a 
medial pallium (cortex-like structure) connected to the thalamus 
(hypothalamus, subthalamus, (dorsal) thalamus and epithala-
mus), which is in line and continuous with the brainstem and 
spinal cord (see Loonen and Ivanova, 2015, 2016b). The hemi-
sphere is small, comprising pallium and subpallium; the subpal-
lium contains an extrapyramidal system with similar components 
and structure to its human equivalent (Grillner and Robertson, 
2016; Stephenson-Jones et al., 2012). The pallidal part of this 
extrapyramidal system contains a glutamatergic nucleus with ter-
minals running to the lateral division of the habenuloid complex: 
the habenula-projecting globus pallidus (GPh). These GPh neu-
rons are a component of a distinct reward-evaluation circuit 
which select actions by (dis)inhibiting ascending dopaminergic 
mesostriatal projections (Stephenson-Jones et al., 2013).
A later evolutionary stage of the human cerebrum is repre-
sented by the frog brain. The forebrain of the humans’ amphib-
ian-like ancestor contains an amygdaloid as well as a striatal 
extrapyramidal system (Moreno and Gonzalez, 2006). The gan-
glionic amygdaloid complex is principally homologous with the 
original lamprey striatopallidal complex, consisting of ‘striatal’ 
central and medial amygdaloid nuclei and a ‘pallidal’ bed nucleus 
of the stria terminalis (Moreno et al., 2012; Loonen, 2013). The 
new amphibian striatal complex consists of a large part which 
corresponds to the human shell part of the accumbens nucleus, 
and a small part giving rise to its core part and the dorsal striatum 
(caudate nucleus and putamen). It should be realized, however, 
that the cortex-like pallium of these amphibian-like ancestors has 
not yet achieved the input analysing and output generating role of 
the human cerebral cortex (see Loonen, 2013), but is still part of 
a more extensive ‘limbic’ behavioural control system including 
almost all of the pallial and subpallial regions (Laberge and Roth, 
2007; Laberge et al., 2008; Roth et al., 2003).
The mammalian extrapyramidal system is, largely, a converg-
ing cortico-striato-thalamo-cortical (CSTC) circuit (see Loonen 
and Ivanova, 2013). The cerebral cortex, including the hip-
pocampus and corticoid amygdala (Heilbronner et al., 2016), is 
connected with the input ganglia of the extrapyramidal system in 
a topographically arranged fashion (Alexander et al., 1986; 
Heimer, 2003; Voogd et al., 1998). This includes the frontal cer-
ebral cortex, which is at the same time target of all the CSTC 
circuits; this organization results in the existence of several re-
entry circuits starting from and ending in the same frontal area 
(Alexander et al., 1986). This suggests the existence of two re-
entry circuits starting from and ending at the anterior cingulate 
cortex (BA24) and subgenual cingulate cortex (BA25), and 
including the core respectively shell part of the accumbens 
nucleus as extrapyramidal entry stations (see Loonen and 
Ivanova, 2016a). These circuits regulate the motivation to obtain 
reward or to avoid distress, and being successful results in feel-
ings of pleasure and happiness. The activity of these re-entry cir-
cuits is regulated by ascending monoaminergic tracts originating 
within the midbrain, and which are, in turn, controlled by the 
habenuloid complex (see Batalla et al., 2017; see Loonen and 
Ivanova, 2016b). In mammals, the amygdaloid and hippocampal 
complexes (which are considered to have evolved directly from 
the forebrain of humans’ earliest vertebrate ancestors) may regu-
late the habenuloid activity via the hypothalamus, septal area and 
mammalian homologue of GPh.
The human-like cerebral cortex is of a relatively recent evolu-
tionary date and is therefore unlikely to have been primarily 
involved in regulating essential behavioural processes. However, 
due to its size and structure, the cerebral cortex may be much 
more capable of interpreting input and generating suitable output 
than the amygdaloid and hippocampal complexes (see Loonen 
and Ivanova, 2017a). Reciprocal connectivity between primary 
brain structures (amygdaloid, hippocampal, and habenuloid com-
plex, as well as structures connecting these) and the neuronal 
networks of the cerebral cortex could enable a far more sophisti-
cated behavioural response to environmental circumstances. This 
reciprocal connectivity also directly and indirectly modulates the 
activity of the ventral striatal re-entry circuits and therefore the 
motivation for reward-seeking and distress-avoiding behaviour.
To conclude, a primary (lamprey-like), secondary (amphib-
ian-like) and tertiary (mammalian-like) forebrain can be distin-
guished according to a Russian doll model. The amygdaloid, 
hippocampal and habenuloid complexes (primary forebrain) 
regulate essential reward-seeking and distress-avoiding behav-
iour, the ventral striatal extrapyramidal complex (secondary fore-
brain) regulates the intensity of these behaviours and the cerebral 
neocortex (tertiary forebrain) enables the sophisticated transla-
tion of sensory input to complex behavioural output.
Evolution of human culture and 
technology from a biological 
perspective
With an estimated age of about 200,000 years, the modern human 
is a relatively young animal species (McDougall et al., 2005). 
Humans have a far larger brain compared with body weight than 
other apes, but the percentage of the human brain accounted for 
by the cerebral cortex is about the same as in other apes (Van 
Dongen, 1998; Voogd et al., 1998). No part of the cerebral cortex, 
including the prefrontal cortex, has become disproportionally 
larger in humans. It has been suggested that the larger size of the 
human brain in comparison with body weight, which enables 
many more elaborate neuronal networks, is the only basis of 
higher intelligence in humans compared with other apes (Gabi 
et al., 2016).
Modern humans may have ‘occurred’ relatively recently; 
human culture has existed for no more than a fraction of that 
period. The control of fire is considered to represent one of our 
most important technological achievements, but the cooking of 
vegetables was actually displayed by early hominins living 
about 780,000 years ago (Melamed et al., 2016). Other investi-
gations support the existence of burning sites from about 1.5 
MYA onwards, and there is evidence of actual hearths from 
around 700,000–400,000 years ago (Gowlett, 2016). Such 
behaviour, therefore, was displayed long before the first mod-
ern humans appeared, and certainly cannot be considered a 
typical modern human accomplishment. Examples of ancient 
human artistic forms are the hand stencils found in cave sites in 
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the Maros karsts of Sulawesi, Indonesia (Aubert et al., 2014). 
The earliest dated images found at these sites had a minimum 
age of 39,900 years (Aubert et al., 2014). The oldest evidence 
of deep-sea fishing is dated at about 42,000 years ago 
(O’Connor et al., 2011), while agriculture appears far later in 
the history of humans (Larson et al., 2014). Plant and animal 
domestication started with the taming of dogs about 15,000 
years ago (MacHugh et al., 2017). Animal domestication 
resulted in ancient settlements at oases, and some of these, for 
example Jericho, later developed into cities. Regulating daily 
living and trading within and between these communities prob-
ably necessitated the development of writing, which occurred 
within the time frame of 10,000–5000 years ago (Gross, 2012; 
Schmandt-Besserat, 2014). The Mesopotamian cuneiform 
script, which was invented circa 3200 bc, can be traced without 
any discontinuity over a period of 10,000 years, from a prehis-
toric antecedent to the present-day alphabet, and is therefore 
considered the oldest form of writing (Schmandt-Besserat, 
2014). Writing is an absolute necessity for technological evo-
lution because it allows communication between persons with-
out any contact in place and time. Particularly, after the 
invention of printing and quite recently digitalization, writing 
can be considered a prerequisite for the founding of our current 
and technologically advanced society. However, it should be 
realized that genuine urbanization started somewhere in the 
19th century, mass human transportation at the beginning of 
the 20th century and the internet in the 1970s. In summary, the 
most primitive human cultural developments started about 
40,000 years ago, the art of human philosophy (which depends 
upon writing) lasts for only up to five millennia, major scien-
tific progress dates from only the last few centuries and the 
most important technological advancements so far are only a 
few decades old at the most.
Considering the timeframes of biological and cultural evolu-
tions, it is highly unlikely that the acquisition of our advanced 
technical and philosophical skills is reflected by important evolu-
tionary neuroanatomical changes. Whenever such changes may 
have occurred, they are probably restrained to a microscopic and/
or biochemical level.
Reason and knowledge
Humans can substitute almost every observation, experience 
and behavioural reaction by spoken or written language sym-
bols. This offers them the opportunity to create a virtual mental 
world which is intermingled with the real physical world and 
results in the set of thoughts and memories designated by the 
term ‘mind’. Consciousness and communication depend upon a 
proper functioning of the cerebral cortex, which may indicate 
that the human mind depends upon the functioning of neuronal 
networks within or involving this part of the brain. The content 
of the individual’s thoughts and mental skills are not reflected 
by the physical construction of these neuronal networks, but 
their quality in certain respects is, so some people can become 
delusional due to dysmorphic salience (Van Os, 2009): it is 
important to note that the content of common delusions in 
Western society has changed during the last century. Mental 
disorders always partly consist of distorted mind activity with-
out a strict biological background. This ‘mind’ content is usu-
ally not accessible for drug treatment.
Consequences for 
neuropsychopharmacology
Two interacting regulatory mechanisms of human behaviour can 
be distinguished: cognitive and emotional (see Loonen and 
Ivanova, 2016c). The first mechanism is operated by a neuronal 
complex consisting largely of the neocortex and its extrapyrami-
dal circuits, and which probably also produces consciousness, 
thoughts and memories. The second is controlled by the amygda-
loid and hippocampal complexes and the hypothalamus and 
upper brainstem, and produces intuitive and automatic behaviour. 
Human conduct consists of a mixture of both types of behav-
iours, each with its own rules, training, recollections and also 
imperfections. Mental disorders are incorporated in both regula-
tory mechanisms, and treatment options can be found in the cog-
nitive as well as the emotional regulatory system. Although 
certain symptoms of mental disorders can be affected by a global 
adaptation of neocortical network activity, drugs are unlikely to 
be suitable to specifically address certain neocortical networks. 
Psychotropic drugs affect components of the emotional regula-
tory system and modulate the activity of the primary and second-
ary forebrain, as defined in the Introduction. Their impact on the 
activity of the primary and secondary forebrains and the interac-
tion within and between them should, in our opinion, be the most 
important subject of study when investigating the psychotropic 
treatment potential of investigational new drugs both in animals 
and in humans.
Selective serotonin agonists and antagonists
At least 17 molecules (tryptophan hydroxylase, monoamine oxi-
dase A, serotonin transporter and 14 serotonin receptors) regulate 
the serotonergic synapse activity (Barnes and Sharp, 1999). 
Serotonin plays a role in almost every integrative function of the 
central nervous system, including mood, anxiety, stress, aggres-
sion, feeding, cognition and sexual behaviour (Olivier, 2015). 
Non-selective stimulation or inhibition of serotonergic neuro-
transmission, therefore, has multiple, and partly opposite, effects; 
this is even more true for the acute and chronic effects of drugs 
that increase serotonin levels since this may also result in adapted 
serotonin (5-HT) receptor sensitivity. 5-HT1a and 5-HT2 recep-
tors in particular play an important role in mediating, for exam-
ple, part of the effects of antidepressant and antipsychotic drugs 
(see Loonen and Ivanova, 2016c, 2016d). Within the cortical 
parts of the amygdaloid complex, excitatory 5-HT2A receptors 
are present on stimulatory glutamatergic pyramidal neurons and 
on inhibitory GABAergic interneurons and GABAergic projec-
tion neurons, which results in mixed behavioural effects. The 
5-HT2C receptor probably exclusively activates the amygdaloid 
complex (by activating cortical pyramidal cells and ganglionic 
GABAergic projection neurons) (Bombardi, 2014). Moreover, 
5-HT2C receptors and, to a lesser extent, 5-HT2A receptors, have 
constitutive activity, which enables clozapine’s considerable 
inverse 5-HT2C agonistic activity (which is consequently inhibi-
tory) (Aloyo et al., 2009). From neuroanatomical studies, it can 
be concluded that serotonin inhibits the release of dopamine 
within the dorsal striatum by affecting 5-HT2C receptors and 
also within the ventral striatum and prefrontal cortex by affecting 
5-HT2A receptors (see Loonen and Ivanova, 2016d). The inverse 
agonistic effect within the dorsal striatum may explain 
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clozapine’s therapeutic effects on cognitive functioning (Meltzer 
and McGurk, 1999; Woodward et al., 2005) by actively increas-
ing activity within the dorsal extrapyramidal circuitry. Other 
atypical antipsychotics are more selectively binding 5-HT2A 
receptors and in combination with their relatively potent dopa-
mine antagonistic activity this would result in less extrapyrami-
dal stimulation of the prefrontal cortex (leaving only direct 
effects within it).
The forebrain of the lamprey might offer a suitable model for 
investigating the effects of drugs affecting 5-HT2 receptors 
within the amygdaloid complex in the absence of functional 
ventral and dorsal extrapyramidal circuitry. The lamprey’s lat-
eral and medial pallium probably correspond largely to (respec-
tively) the human corticoid amygdala and hippocampal complex, 
and their subpallium to the human extended amygdala. Ocaña 
et al. (2015) present an example of how ‘behavioural’ conse-
quences of neuronal stimulation can be studied in these animals: 
they looked at the effects of electrical microstimulation of the 
lateral pallium after surgical exposure of the dorsal surface of 
the brain whilst the trunk and tail were kept intact and allowed 
to move freely. When the animals had fully recovered from the 
effects of anaesthesia, the researchers measured how stimulation 
of different areas could elicit eye, orienting, swimming and 
mouth movements. In lampreys, the GPh also receives direct 
input from the lateral pallium and has an important role in evalu-
ating motor programmes (Stephenson-Jones et al., 2013). The 
study of the influence of modulation of the activity of GPh neu-
rons on movement related to reward seeking with common and 
novel neuropharmacological techniques (Nair et al., 2013) could 
possibly be translated into new treatments for certain stress-
induced or habit-related disorders.
A comparison with the behavioural effects in amphibians 
could conceivably offer possibilities to study the influence on the 
ventral extrapyramidal system in the lack of the dorsal compo-
nent. The activity of monoaminergic midbrain-to-forebrain pro-
jections is regulated by the habenuloid complex (Figure 1): this 
pathway was very well conserved during the evolution of our 
vertebrate ancestors, which therefore offers the possibility of 
study in lampreys and amphibians of how serotonergic input to 
the primary and secondary forebrain is originally regulated.
Selective pharmacological modulation of the 
complex emotional response
In lampreys, motor behaviour is primarily controlled by a striato-
pallidal system (within the subpallium of the forebrain) which 
regulates the activity of specific motor centres within the hypo-
thalamus and upper brainstem (Grillner et al., 2008; Robertson 
et al., 2014). Because in humans the majority of the lamprey stri-
atopallidal system was incorporated within the extended amyg-
dala, this control is likely to be reflected by input from the 
extended amygdala to hypothalamus and brainstem (Figure 2). 
The amygdala receives massive sensory input from the tertiary 
forebrain (Freese and Amaral, 2009; Pitkänen, 2000) and plays 
an essential role in selecting the information which is most rele-
vant for current wellbeing: this selection process is termed ‘sali-
ence’ (Aleman and Kahn, 2005; Berridge et al., 2009; Pryce, 
2018). In interaction with contextual (memorized) details sup-
plied by the hippocampus (Chun, 2000; Lee and Lee, 2013; 
Kitamura, 2017), it activates hypothalamic and brainstem centres 
to produce a relevant emotional response (such as fear, anger, 
love, appetite, sexual desire or power dominance) (Sewards and 
Figure 1. Scheme showing the connectivity of the amygdalo-hippocampal system to the midbrain through the habenular complex (adapted from 
Loonen and Ivanova, 2016b).
CTX: cerebral cortex; DR: dorsal raphe nucleus; DTg: dorsal tegmental nucleus; GPh: habenula-projecting part of the globus pallidus; IPN: interpeduncular nucleus; LHb: 
lateral habenula; MHb: medial habenula; PHC: parahippocampal cortex; RMTg: rostromedial tegmental nucleus; VTA: ventral tegmental area.
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Sewards, 2003). We have hypothesized that the intensity of these 
emotional behaviours (motivation) is regulated by two re-entry 
circuits starting and ending at the anterior cingulate cortex 
(BA24) and subgenual cingulate cortex (BA25), and including 
the core and shell part of the accumbens nucleus as first relay 
stations. In turn, these re-entry circuits are controlled by the 
habenuloid complex affecting the activity of monoaminergic 
ascending pathways from the midbrain (see Loonen and Ivanova, 
2016a, 2016b, 2017b, 2018). The habenula is a complex of at 
least 15 nuclei in the epithalamus which can be divided into 
medial and lateral divisions (Aizawa et al., 2012; Andres et al., 
1999; Wagner et al., 2014). Major input into the medial division 
comes from two medial septal nuclei and the diagonal band of 
Broca via the stria medullaris (Klemm, 2004). The lateral divi-
sion receives first order inputs from the lateral preoptic area, the 
lateral hypothalamus, bed nucleus of the stria terminalis and 
(other) basal ganglia (Klemm, 2004; Matthews Felton et al., 
1999). In addition, limbic neocortical areas – particularly anterior 
insular, anterior cingulate, prelimbic and infralimbic cortices – 
project to the lateral division (Kim and Lee, 2012), as the hip-
pocampus does (Matthews Felton et al., 1999). These neocortical 
areas could modulate the input from the amygdaloid complex to 
the habenula, which we consider primary. The neurochemistry of 
this putatively primary connectivity is shown in Figure 1. The 
described corticohabenular pathway can be considered to repre-
sent the mechanism along which neocortical networks (cogni-
tion) influence the intensity of reward-seeking behaviour 
(emotional drive).
In order to achieve an objective, animals need to select one 
element of the available behavioural repertoire and evaluate its 
outcome in order to determine whether the goal was achieved 
(Stephenson-Jones et al., 2013). The basal ganglia play a key role 
in both action selection and action evaluation. In lampreys, the 
circuitry which selects and evaluates behaviour is located in sep-
arate, non-overlapping parts of the pallidum. In these ancient ani-
mals, the lateral GPh receives direct excitatory projections from 
the animal’s pallium, inhibitory input exclusively from strioso-
mal striatal neurons and inhibitory dopaminergic feedback 
(Stephenson-Jones et al., 2013). Glutamatergic GPh neurons 
with a similar function have been identified in mice and non-
human primates (rhesus monkeys) (Hong and Hikosaka, 2013; 
Stephenson-Jones et al., 2016). In humans, these neurons of the 
border region of the globus pallidus could be involved in termi-
nating specific actions or thoughts, so their failure could play an 
important role in causing compulsions or obsessions. We have 
hypothesized that also the secondary and primary forebrain con-
tains GPh neurons, which could then be localized within the ven-
tral pallidum and bed nucleus of the stria terminalis. These would 
be suitable candidates, thus putative pharmacological targets, to 
be implicated in causing apathy and impulsivity, craving and 
anhedonia, as well as anxiety and panic.
Ketamine’s and varenicline’s mechanism of 
action
Since the randomized, double-blind, placebo-controlled trial of 
intravenous treatment with a subanaesthetic dose of ketamine 
hydrochloride in seven depressed patients by Berman and col-
leagues (2000) the therapeutic effects of this N-methyl-D-aspartate 
Figure 2. Scheme showing the initiation and execution of the emotional response.
BST: bed nucleus of the stria terminalis; CA: corticoid amygdala; CM: centromedial amygdala; dPFC: dorsolateral prefrontal cortex; MC: motor cortex; mPFC: medial prefron-
tal cortex; PAG: periaqueductal grey; PMC: premotor cortex; SMC: supplementary motor cortex.
1282 Journal of Psychopharmacology 32(12)
receptor antagonist in patients with depression has been exten-
sively studied (Andrade, 2017a, 2017b, 2017c, 2017d, 2017e). 
Ketamine was also discovered to have obsession-alleviating effects 
in patients with obsessive–compulsive disorder (Rodriguez et al., 
2013). However, although Ketamine is well known to affect the 
activity of the lateral habenula (Yang et al., 2018; Zanos and 
Gould, 2018) and the preliminary positron emission tomography 
findings of Carlson and co-workers also indicated that ketamine 
decreased the activity of the right habenula in depressed patients 
(Carlson et al., 2013), not a single neuroimaging study describes 
ketamine’s possible influence on GPh neurons (Ionescu et al., 
2018). This is probably due to the habenula’s relatively small size 
in humans, which complicates the imaging of this pallido-habenu-
lar connectivity when this issue is not specifically addressed 
(Batalla et al., 2017). Nevertheless, blocking the activity of gluta-
matergic GPh neurons would disinhibit ascending dopaminergic 
neurons and increase the activity of the reward-seeking circuitry, 
resulting in an improvement of depressive symptoms. This would 
make this mechanism a very good candidate to explain ketamine’s 
acute antidepressant effects. Moreover, affecting the activity of 
GPh neurons could link ketamine’s activity to brain-derived neuro-
trophic factor (BDNF) (Loonen and Ivanova, 2016c; Loonen et al., 
2017; Zanos and Gould, 2018). BDNF expression plays a role in, 
and BDNF is a biomarker in, both unipolar and bipolar depression 
(Fernandes et al., 2015; Jentsch et al., 2015, Munkholm et al., 
2016; Wu et al., 2014). This antidepressant mechanism deserves 
further study, and, in our opinion, could be a suitable starting point 
for the development of new antidepressant treatments. This would 
certainly be a more selective mechanism, and preferable to affect-
ing cortico-habenular connectivity.
Varenicline is a partial α4-β2 nicotinic acetylcholine receptor 
agonist which is prescribed as an aid to smoking cessation 
(Jiménez-Ruiz et al., 2009). Numerous reports illustrate vareni-
cline’s potential to induce neuropsychiatric side effects (includ-
ing depression) (Ahmed et al., 2013; Moore et al., 2011) and 
aggression towards others (Moore et al., 2010a, 2010b). The 
medial habenula is widely known for its abundance of nicotinic 
acetylcholine receptors, including α3, α4, α5, β2 and/or β4 con-
taining receptor subtypes (Antolin-Fontes et al., 2015; Leslie 
et al., 2013; Viswanath et al., 2014). The medial habenula is con-
nected via the interpeduncular nucleus to the upper raphe nuclei 
(Figure 3) (Antolin-Fontes et al., 2015) and affecting these nico-
tinic receptors may result in activation of 5-HT pathways to the 
amygdaloid and hippocampal complexes. This would link varen-
icline-induced hostility to aggression induced by selective sero-
tonin reuptake inhibitors (Moore et al., 2010b).
Conclusions
The present paper describes two interacting brain mechanisms 
independently regulating rational and emotional behaviours. 
Motivation to exhibit these behaviours depends upon the activity of 
two ventral extrapyramidal re-entry circuits, including the core and 
shell part of the nucleus accumbens, respectively. These are hypoth-
esized to belong to the secondary forebrain. According to this 
model, the primary forebrain is essentially similar to the brain of the 
earliest vertebrate ancestors of humans, which, in turn, is similar to 
the forebrain of the lamprey. The cerebral neocortex evolved rela-
tively late, and is the essential part of the tertiary brain producing 
thoughts and language. As the neuronal networks interact with the 
primary and secondary forebrain, they can modulate the emotional 
response which is generated by the primary brain. An essential 
component of the primary brain is the habenuloid complex, which 
regulates the activity of ascending dopaminergic, adrenergic and 
Figure 3. Simplified representation of the connectivity through the epithalamus.
GPh: habenula-projecting globus pallidus; IPN: interpeduncular nucleus; LHb: lateral habenula; MHb: medial habenula; RMTg: rostromedial tegmental nucleus; SNc: sub-
stantia nigra, pars compacta; VTA: ventral tegmental nucleus.
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serotonergic pathways, hence the activity of the three components 
of the forebrain. Whether the goal of the behavioural response is 
reached is evaluated by a system including glutamatergic GPh neu-
rons which regulates the activity of ascending dopaminergic path-
ways. It is postulated that these GPh neurons are targeted by a 
subanaesthetic dosage of ketamine. The medial habenular division 
is enriched with nicotinergic receptors and primarily regulates the 
activity of ascending adrenergic and serotonergic pathways. It is 
suggested that new selective treatment strategies can be developed 
by studying the modulatory mechanism in relatively ancient non-
mammalian animal species with specifically addressing mecha-
nisms to affect the functioning of GPh neurons.
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